"The aim of this white paper is to demonstrate how GE Healthcare Life Sciences single-use products can be applied in the field of vaccine manufacturing. The white
paper includes a brief discussion around modern vaccine processes, followed by a case study showing the scale-up of upstream and downstream processes for the production of a cell based live attenuated influenza virus using single-use ReadyToProcess technology."- GE Healthcare Life Sciences
Download this whitepaper courtesy of GE Healthcare Life Sciences and find out more about using ReadyToProcess equipment:
- How it leads to improved manufacturing agility and productivity
- Reduced environmental impact
- Case study: production of Influenza virus using ReadyToProcess single-use equipment
- How it can be upstream processing
- How it compares to regulatory specifications
Download your copy here.